Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00142532 · ClinicalTrials.gov registry record · Phase 3

Acupuncture for Post-Thoracotomy Pain

A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 3
Development phase
162
Enrollment target

NCT00142532: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00142532 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 162 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00142532, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 3
Development phase
162 participants
Enrollment target

Study Summary

Pain after surgery for lung cancer (thoracotomy) may persist for years and require long-term analgesic use. Prior studies have shown that acupuncture reduces pain and medication use in the early post-operative period after abdominal surgery, suggesting that acupuncture may have a role in preventing chronic post-thoracotomy pain. This study is being done in order to determine the effects of acupuncture on pain in patients undergoing surgery for lung cancer.

Interventions

  • PROCEDURE Acupuncture and Questionnaires
  • PROCEDURE Placebo Acupuncture, Questionnaires

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2005-06
Est. Completion 2008-01
Phase Phase 3

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00142532

The ClinicalTrials.gov registry entry for NCT00142532 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Acupuncture and Questionnaires is the first listed.

NCT00142532 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00142532 about?

NCT00142532 is a clinical study titled "Acupuncture for Post-Thoracotomy Pain". Pain after surgery for lung cancer (thoracotomy) may persist for years and require long-term analgesic use. Prior studies have shown that acupuncture reduces pain and medication use in the early post-operative period after abdominal surgery, suggesting that acupuncture may have a role in preventing ...

What is the current status of trial NCT00142532?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 162 participants. The study started on 2005-06. Estimated completion is 2008-01.

What interventions are being tested in trial NCT00142532?

The interventions under investigation include: Acupuncture and Questionnaires (PROCEDURE), Placebo Acupuncture, Questionnaires (PROCEDURE).

Who is sponsoring clinical trial NCT00142532?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.